201 related articles for article (PubMed ID: 36112223)
1. Cross-regional homeostatic and reactive glial signatures in multiple sclerosis.
Trobisch T; Zulji A; Stevens NA; Schwarz S; Wischnewski S; Öztürk M; Perales-Patón J; Haeussler M; Saez-Rodriguez J; Velmeshev D; Schirmer L
Acta Neuropathol; 2022 Nov; 144(5):987-1003. PubMed ID: 36112223
[TBL] [Abstract][Full Text] [Related]
2. Diversity and Function of Glial Cell Types in Multiple Sclerosis.
Schirmer L; Schafer DP; Bartels T; Rowitch DH; Calabresi PA
Trends Immunol; 2021 Mar; 42(3):228-247. PubMed ID: 33593693
[TBL] [Abstract][Full Text] [Related]
3. Comparing RNA-sequencing datasets from astrocytes, oligodendrocytes, and microglia in multiple sclerosis identifies novel dysregulated genes relevant to inflammation and myelination.
Drake SS; Zaman A; Simas T; Fournier AE
WIREs Mech Dis; 2023 Mar; 15(2):e1594. PubMed ID: 36600404
[TBL] [Abstract][Full Text] [Related]
4. Macroglial diversity: white and grey areas and relevance to remyelination.
Werkman IL; Lentferink DH; Baron W
Cell Mol Life Sci; 2021 Jan; 78(1):143-171. PubMed ID: 32648004
[TBL] [Abstract][Full Text] [Related]
5. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
[TBL] [Abstract][Full Text] [Related]
6. Neuronal vulnerability and multilineage diversity in multiple sclerosis.
Schirmer L; Velmeshev D; Holmqvist S; Kaufmann M; Werneburg S; Jung D; Vistnes S; Stockley JH; Young A; Steindel M; Tung B; Goyal N; Bhaduri A; Mayer S; Engler JB; Bayraktar OA; Franklin RJM; Haeussler M; Reynolds R; Schafer DP; Friese MA; Shiow LR; Kriegstein AR; Rowitch DH
Nature; 2019 Sep; 573(7772):75-82. PubMed ID: 31316211
[TBL] [Abstract][Full Text] [Related]
7. Single-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions.
Elkjaer ML; Hartebrodt A; Oubounyt M; Weber A; Vitved L; Reynolds R; Thomassen M; Rottger R; Baumbach J; Illes Z
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200213. PubMed ID: 38564686
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role.
Waller R; Woodroofe MN; Wharton SB; Ince PG; Francese S; Heath PR; Cudzich-Madry A; Thomas RH; Rounding N; Sharrack B; Simpson JE
J Neuroimmunol; 2016 Oct; 299():139-146. PubMed ID: 27725112
[TBL] [Abstract][Full Text] [Related]
9. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis.
Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
Acta Neuropathol Commun; 2019 Dec; 7(1):205. PubMed ID: 31829262
[TBL] [Abstract][Full Text] [Related]
10. Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS.
Windener F; Grewing L; Thomas C; Dorion MF; Otteken M; Kular L; Jagodic M; Antel J; Albrecht S; Kuhlmann T
Acta Neuropathol; 2024 May; 147(1):82. PubMed ID: 38722375
[TBL] [Abstract][Full Text] [Related]
11. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis.
Pitt D; Nagelmeier IE; Wilson HC; Raine CS
Neurology; 2003 Oct; 61(8):1113-20. PubMed ID: 14581674
[TBL] [Abstract][Full Text] [Related]
12. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB
J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients.
Kular L; Ewing E; Needhamsen M; Pahlevan Kakhki M; Covacu R; Gomez-Cabrero D; Brundin L; Jagodic M
Epigenetics; 2022 Nov; 17(11):1311-1330. PubMed ID: 35094644
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous fate choice of genetically modulated adult neural stem cells in gray and white matter of the central nervous system.
Beyer F; Jadasz J; Samper Agrelo I; Schira-Heinen J; Groh J; Manousi A; Bütermann C; Estrada V; Reiche L; Cantone M; Vera J; Viganò F; Dimou L; Müller HW; Hartung HP; Küry P
Glia; 2020 Feb; 68(2):393-406. PubMed ID: 31633850
[TBL] [Abstract][Full Text] [Related]
15. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer's disease.
Sadick JS; O'Dea MR; Hasel P; Dykstra T; Faustin A; Liddelow SA
Neuron; 2022 Jun; 110(11):1788-1805.e10. PubMed ID: 35381189
[TBL] [Abstract][Full Text] [Related]
16. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
Koning N; Swaab DF; Hoek RM; Huitinga I
J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
[TBL] [Abstract][Full Text] [Related]
17. Connexins in oligodendrocytes and astrocytes: Possible factors for demyelination in multiple sclerosis.
Xia CY; Xu JK; Pan CH; Lian WW; Yan Y; Ma BZ; He J; Zhang WK
Neurochem Int; 2020 Jun; 136():104731. PubMed ID: 32201280
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
Markoullis K; Sargiannidou I; Schiza N; Roncaroli F; Reynolds R; Kleopa KA
J Neuropathol Exp Neurol; 2014 Sep; 73(9):865-79. PubMed ID: 25101702
[TBL] [Abstract][Full Text] [Related]
19. White matter astrocytes in health and disease.
Lundgaard I; Osório MJ; Kress BT; Sanggaard S; Nedergaard M
Neuroscience; 2014 Sep; 276():161-73. PubMed ID: 24231735
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of oligodendrocytes within astrocytes in demyelinating lesions.
Ghatak NR
J Neuropathol Exp Neurol; 1992 Jan; 51(1):40-6. PubMed ID: 1740673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
